Advancing health system legislative and regulatory issues including: programs to reduce health disparities; the development of a collaborative, interdisciplinary translational cancer research program; expand access to specialized health care through telehealth; the importance of developing advanced function fabrics for our armed services; and the role of computational medicine in understanding of disease onset and progression.
Duration: January 31, 2017
to
present
General Issues: Budget/Appropriations , Health Issues , Medicare/Medicaid , Medical/Disease Research/Clinical Labs , Education , Taxation/Internal Revenue Code
Spending: about $1,740,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2017: House of Representatives, U.S. Senate, Health & Human Services - Dept of (HHS)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
John Bartrum Dec. 2009-Feb. 2017, House of Rep, Appropriations Committee, Prof. Staff Member; Oct. 2006-Dec. 2009, NIH, Assoc. Director, Budget Office; June 2001-Oct. 2006, OMG, Natl Sec. Div., Senior Examiner.
Meg Gilley 2005-July 2010: LA and Senior PA, Cong. Jack Kingston
Katie Novaria Aug. 07-Dec 08-SA, Rep. Joe Knollenberg; Jan 09-Dec 10-SA/Press Assist, Rep. Fred Upton; Jan.11-March '13-Legis.Clerk, House Com. on Energy and Commerce;April '13-Feb. '16- Pro. Staff Member, House Com. Energy and Commerce, Sub. on Health
Emily Wilson Aug 2011-June 2012, Staff Asst, Cong. Paul Broun;
May 2010-July 2011, Constit. Serv. Rep., Cong. Paul Broun; Aug 2009-May2010, Intern, Cong. Paul Broun; June-Aug 2009, Intern, Cong. Zach Wamp;
Charles Brereton Sept.-Dec. 2014: Intern, Office of Speaker John Boehner; Sept.-Dec. 2016: Intern Office of Senator Richard Burr
Sept.-Dec. 2014: Intern, Office of Speaker John Boehner; Sept.-Dec. 2016: Intern, Office of Senator Richard Burr
David LesStrang (no contact with House before 8/18/19) 1996 -2001: Dep. COS and LD, Rep. Jerry Lewis; Jan. 2005- Jan. 2007: Dep. Staff Dir., Com. on Approps; Jan. 2007-Jan. 2011: Professional Staff, House Com.on Approps; Jan. 2011-Aug. 2018: Clerk, Sub. on Interior, Environ. and Related Agencies.
David LesStrang 1996 -2001: Dep. COS and LD, Rep. Jerry Lewis; Jan. 2005- Jan. 2007: Dep. Staff Dir., Com. on Approps; Jan. 2007-Jan. 2011: Professional Staff, House Com.on Approps; Jan. 2011-Aug. 2018: Clerk, Sub. on Interior, Environ. and Related Agencies.
Callan Smith Aug. 2010-Oct. 2012: Policy Research Assistant, Senate Committee in Finance; Nov. 2009-Aug. 2010: Staff Assistant to Sen. Max Baucus
John Wyand n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Squire Patton Boggs lobbied for Thomas Jefferson University , earning $60,000. The report was filed on April 10.
Original Filing: 301547697.xml
Lobbying Issues
Advancing health system legislative and regulatory issues including: programs to reduce health disparities; the development of a collaborative, interdisciplinary translational cancer research program; expand access to specialized health care through telehealth; the importance of developing advanced function fabrics for our armed services; and the role of computational medicine in understanding of disease onset and progression.
4th Quarter, 2023
In Q4, Squire Patton Boggs lobbied for Thomas Jefferson University , earning $60,000. The report was filed on Jan. 15.
Original Filing: 301524587.xml
Lobbying Issues
Advancing health system legislative and regulatory issues including: programs to reduce health disparities; the development of a collaborative, interdisciplinary translational cancer research program; expand access to specialized health care through telehealth; the importance of developing advanced function fabrics for our armed services; and the role of computational medicine in understanding of disease onset and progression.
3rd Quarter, 2023
In Q3, Squire Patton Boggs lobbied for Thomas Jefferson University , earning $60,000. The report was filed on Oct. 10, 2023.
Original Filing: 301499021.xml
Lobbying Issues
Advancing health system legislative and regulatory issues including: programs to reduce health disparities; the development of a collaborative, interdisciplinary translational cancer research program; expand access to specialized health care through telehealth; the importance of developing advanced function fabrics for our armed services; and the role of computational medicine in understanding of disease onset and progression.
2nd Quarter, 2023
In Q2, Squire Patton Boggs lobbied for Thomas Jefferson University , earning $60,000. The report was filed on July 14, 2023.
Original Filing: 301476418.xml
Lobbying Issues
Advancing health system legislative and regulatory issues including: programs to reduce health disparities; the development of a collaborative, interdisciplinary translational cancer research program; expand access to specialized health care through telehealth; the importance of developing advanced function fabrics for our armed services; and the role of computational medicine in understanding of disease onset and progression.
1st Quarter, 2023
In Q1, Squire Patton Boggs lobbied for Thomas Jefferson University , earning $60,000. The report was filed on April 19, 2023.
Original Filing: 301456380.xml
Lobbying Issues
Advancing health system legislative and regulatory issues including: programs to reduce health disparities; the development of a collaborative, interdisciplinary translational cancer research program; expand access to specialized health care through telehealth; the importance of developing advanced function fabrics for our armed services; and the role of computational medicine in understanding of disease onset and progression.
4th Quarter, 2022
In Q4, Squire Patton Boggs lobbied for Thomas Jefferson University , earning $60,000. The report was filed on Jan. 18, 2023.
Original Filing: 301430282.xml
Lobbying Issues
Advancing health system legislative and regulatory issues including: programs to reduce health disparities; the development of a collaborative, interdisciplinary translational cancer research program; expand access to specialized health care through telehealth; the importance of developing advanced function fabrics for our armed services; and the role of computational medicine in understanding of disease onset and progression.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2022
In Q3, Squire Patton Boggs lobbied for Thomas Jefferson University , earning $60,000. The report was filed on Oct. 13, 2022.
Original Filing: 301403776.xml
Lobbying Issues
Advancing health system legislative and regulatory issues including: programs to reduce health disparities; the development of a collaborative, interdisciplinary translational cancer research program; expand access to specialized health care through telehealth; the importance of developing advanced function fabrics for our armed services; and the role of computational medicine in understanding of disease onset and progression.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2022
In Q2, Squire Patton Boggs lobbied for Thomas Jefferson University , earning $60,000. The report was filed on July 13, 2022.
Original Filing: 301379938.xml
Lobbying Issues
Advancing health system legislative and regulatory issues including: programs to reduce health disparities; the development of a collaborative, interdisciplinary translational cancer research program; expand access to specialized health care through telehealth; the importance of developing advanced function fabrics for our armed services; and the role of computational medicine in understanding of disease onset and progression.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2022
In Q1, Squire Patton Boggs lobbied for Thomas Jefferson University , earning $60,000. The report was filed on April 19, 2022.
Original Filing: 301363272.xml
Lobbying Issues
Advancing health system legislative and regulatory issues including: programs to reduce health disparities; the development of a collaborative, interdisciplinary translational cancer research program; expand access to specialized health care through telehealth; the importance of developing advanced function fabrics for our armed services; and the role of computational medicine in understanding of disease onset and progression.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2021
In Q4, Squire Patton Boggs lobbied for Thomas Jefferson University , earning $60,000. The report was filed on Jan. 17, 2022.
Original Filing: 301324270.xml
Lobbying Issues
Advancing health system legislative and regulatory issues including: programs to reduce health disparities; the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program; expand access to specialized health care through telehealth; the importance of developing advanced function fabrics for our armed services; and the role of computational medicine in understanding of disease onset and progression.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2021
In Q3, Squire Patton Boggs lobbied for Thomas Jefferson University , earning $60,000. The report was filed on Oct. 13, 2021.
Original Filing: 301298473.xml
Lobbying Issues
Advancing health system legislative and regulatory issues including: programs to reduce health disparities; the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program; expand access to specialized health care through telehealth; the importance of developing advanced function fabrics for our armed services; and the role of computational medicine in understanding of disease onset and progression.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2021
In Q2, Squire Patton Boggs lobbied for Thomas Jefferson University , earning $60,000. The report was filed on July 19, 2021.
Original Filing: 301281640.xml
Lobbying Issues
Advancing health system legislative and regulatory issues including: programs to reduce health disparities; the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program; expand access to specialized health care through telehealth; the importance of developing advanced function fabrics for our armed services; and the role of computational medicine in understanding of disease onset and progression.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2021
In Q1, Squire Patton Boggs lobbied for Thomas Jefferson University , earning $60,000. The report was filed on April 20, 2021.
Original Filing: 301261873.xml
Lobbying Issues
Advancing health system legislative and regulatory issues including: programs to reduce health disparities; the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program; expand access to specialized health care through telehealth; the importance of developing advanced function fabrics for our armed services; and the role of computational medicine in understanding of disease onset and progression.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2020
In Q4, Squire Patton Boggs lobbied for Thomas Jefferson University , earning $60,000. The report was filed on Jan. 18, 2021.
Original Filing: 301233400.xml
Lobbying Issues
Advancing health system legislative and regulatory issues including: programs to reduce health disparities; the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program; expand access to specialized health care through telehealth; the importance of developing advanced function fabrics for our armed services; and the role of computational medicine in understanding of disease onset and progression.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2020
In Q3, Squire Patton Boggs lobbied for Thomas Jefferson University , earning $60,000. The report was filed on Oct. 14, 2020.
Original Filing: 301209793.xml
Lobbying Issues
Advancing health system legislative and regulatory issues including: programs to reduce health disparities; the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program; expand access to specialized health care through telehealth; the importance of developing advanced function fabrics for our armed services; and the role of computational medicine in understanding of disease onset and progression.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Health reform; COVID-19 matters; health insurance; surprise medical billing and drug pricing reform; Provider Relief Fund.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicaid expansion; DSH payments. Medicaid Fiscal Accountability Regulation;Affordable Care Act
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2020
In Q2, Squire Patton Boggs lobbied for Thomas Jefferson University , earning $60,000. The report was filed on July 8, 2020.
Original Filing: 301186071.xml
Lobbying Issues
Advancing health system legislative and regulatory issues including: programs to reduce health disparities; the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program; expand access to specialized health care through telehealth; the importance of developing advanced function fabrics for our armed services; and the role of computational medicine in understanding of disease onset and progression.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Health reform; COVID-19 matters; and health insurance; surprise medical billing and drug pricing reform.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicaid expansion; DSH payments. Medicaid Fiscal Accountability Regulation.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2020
In Q1, Squire Patton Boggs lobbied for Thomas Jefferson University , earning $60,000. The report was filed on April 16, 2020.
Original Filing: 301168245.xml
Lobbying Issues
Advancing health system legislative and regulatory issues including: programs to reduce health disparities; the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program; expand access to specialized health care through telehealth; the importance of developing advanced function fabrics for our armed services; and the role of computational medicine in understanding of disease onset and progression.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Health reform; COVID-19 matters; and health insurance; surprise medical billing and drug pricing reform.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Advancing health system legislative and regulatory issues including: the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Medicaid expansion; DSH payments. Medicaid Fiscal Accountability Regulation.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2019
In Q4, Squire Patton Boggs lobbied for Thomas Jefferson University , earning $60,000. The report was filed on Jan. 21, 2020.
Original Filing: 301124283.xml
Lobbying Issues
Advancing health system legislative and regulatory issues including: programs to reduce health disparities; the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program; expand access to specialized health care through telehealth; the importance of developing advanced function fabrics for our armed services; and the role of computational medicine in understanding of disease onset and progression.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Health reform; 340B drug pricing; and health insurance; surprise medical billing and drug pricing reform.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Advancing health system legislative and regulatory issues including: the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Medicaid expansion; DSH payments.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2019
In Q3, Squire Patton Boggs lobbied for Thomas Jefferson University , earning $60,000. The report was filed on Oct. 17, 2019.
Original Filing: 301068102.xml
Lobbying Issues
Advancing health system legislative and regulatory issues including: programs to reduce health disparities; the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program; expand access to specialized health care through telehealth; the importance of developing advanced function fabrics for our armed services; and the role of computational medicine in understanding of disease onset and progression.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Health reform; 340B drug pricing; and health insurance; surprise medical billing and drug pricing reform.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Advancing health system legislative and regulatory issues including: the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Medicaid expansion; DSH payments.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2019
In Q2, Squire Patton Boggs lobbied for Thomas Jefferson University , earning $60,000. The report was filed on July 18, 2019.
Original Filing: 301049068.xml
Lobbying Issues
Advancing health system legislative and regulatory issues including: programs to reduce health disparities; the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program; expand access to specialized health care through telehealth; the importance of developing advanced function fabrics for our armed services; and the role of computational medicine in understanding of disease onset and progression.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Higher Education Act reauthorization proposals.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Health reform; 340B drug pricing; and health insurance; surprise medical billing and drug pricing reform.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Advancing health system legislative and regulatory issues including: the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Medicaid expansion; DSH payments.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2019
In Q1, Squire Patton Boggs lobbied for Thomas Jefferson University , earning $60,000. The report was filed on April 18, 2019.
Original Filing: 301028053.xml
Lobbying Issues
Advancing health system legislative and regulatory issues including: programs to reduce health disparities; the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program; expand access to specialized health care through telehealth; the importance of developing advanced function fabrics for our armed services; and the role of computational medicine in understanding of disease onset and progression.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Higher Education Reauthorization.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Health reform; 340B drug pricing; and health insurance.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Advancing health system legislative and regulatory issues including: the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Medicaid expansion; DSH payments.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2018
In Q4, Squire Patton Boggs lobbied for Thomas Jefferson University , earning $60,000. The report was filed on Jan. 10, 2019.
Original Filing: 301003478.xml
Lobbying Issues
Advancing health system legislative and regulatory issues including: programs to reduce health disparities; the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program; and expand access to specialized health care through telehealth; the importance of developing advanced function fabrics for our armed services; and the role of computational medicine in understanding of disease onset and progression.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
PROSPER Act and other Higher Education Act reauthorization proposals.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Health reform; 340B drug pricing; and health insurance.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Advancing health system legislative and regulatory issues including: the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Medicaid expansion; DSH payments.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2018
In Q3, Squire Patton Boggs lobbied for Thomas Jefferson University , earning $60,000. The report was filed on Oct. 12, 2018.
Original Filing: 300984593.xml
Lobbying Issues
Advancing health system legislative and regulatory issues including: programs to reduce health disparities; the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program; and expand access to specialized health care through telehealth.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
PROSPER Act and other Higher Education Act reauthorization proposals.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Health reform; 340B drug pricing; and health insurance.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Advancing health system legislative and regulatory issues including: the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Medicaid expansion; DSH payments.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Matters related to the impact of tax reform on higher education and health systems.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2018
In Q2, Squire Patton Boggs lobbied for Thomas Jefferson University , earning $60,000. The report was filed on July 17, 2018.
Original Filing: 300966230.xml
Lobbying Issues
Advancing health system legislative and regulatory issues including: programs to reduce health disparities; the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program; and expand access to specialized health care through telehealth.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
PROSPER Act and other Higher Education Act reauthorization proposals.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Health reform; 340B drug pricing; and health insurance.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Advancing health system legislative and regulatory issues including: the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Medicaid expansion; DSH payments.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Matters related to the impact of tax reform on higher education and health systems.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2018
In Q1, Squire Patton Boggs lobbied for Thomas Jefferson University , earning $60,000. The report was filed on April 17, 2018.
Original Filing: 300946515.xml
Lobbying Issues
Advancing health system legislative and regulatory issues including: programs to reduce health disparities; the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program; and expand access to specialized health care through telehealth.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
PROSPER Act and other Higher Education Act reauthorization proposals.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Health reform; 340B drug pricing; and health insurance.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Advancing health system legislative and regulatory issues including: the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Medicaid expansion; DSH payments.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Matters related to the impact of tax reform on higher education and health systems.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2017
In Q4, Squire Patton Boggs lobbied for Thomas Jefferson University , earning $60,000. The report was filed on Jan. 17, 2018.
Original Filing: 300925527.xml
Lobbying Issues
Advancing health system legislative and regulatory issues including: programs to reduce health disparities; the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program; and expand access to specialized health care through telehealth.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Health reform; 340B drug pricing; and health insurance.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Advancing health system legislative and regulatory issues including: the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Medicaid expansion; DSH payments.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Matters related to the impact of tax reform on higher education and health systems.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2017
In Q3, Squire Patton Boggs lobbied for Thomas Jefferson University , earning $60,000. The report was filed on Oct. 17, 2017.
Original Filing: 300905837.xml
Lobbying Issues
Advancing health system legislative and regulatory issues including: programs to reduce health disparities; the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program; and expand access to specialized health care through telehealth.
Type of Issue
Budget/Appropriations/Disease Research/Clinical Labs/Medicaid
2nd Quarter, 2017
In Q2, Squire Patton Boggs lobbied for Thomas Jefferson University , earning $60,000. The report was filed on Dec. 6, 2017.
Original Filing: 300919982.xml
Lobbying Issues
Advancing health system legislative and regulatory issues including: programs to reduce health disparities; the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program; and expand access to specialized health care through telehealth.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Budget/Appropriations/Medicaid
1st Quarter, 2017
Squire Patton Boggs amended a lobbying report for representation of Thomas Jefferson University in Q12017 on June 15, 2017.
Original Filing: 300881113.xml
Lobbying Issues
Advancing health system legislative and regulatory issues including: programs to reduce health disparities; the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program; and expand access to specialized health care through telehealth.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Budget/Appropriations/Disease Research/Clinical Labs/Medicaid
1st Quarter, 2017
In Q1, Squire Patton Boggs lobbied for Thomas Jefferson University , earning $60,000. The report was filed on April 19, 2017.
Original Filing: 300870024.xml
Lobbying Issues
Advancing health system legislative and regulatory issues including: programs to reduce health disparities; the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program; and expand access to specialized health care through telehealth.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Budget/Appropriations/Disease Research/Clinical Labs/Medicaid
1st Quarter, 2017
Squire Patton Boggs filed a lobbying registration on March 31, 2017 to represent Thomas Jefferson University, effective Jan. 31, 2017.
Original Filing: 300862092.xml
Issue(s) they said they’d lobby about: Advancing health system regulatory issues; programs to reduce health disparities, the development of a collaborative, interdisciplinary translational cancer research program, and expand access to specialized health care through telehealth. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...